Cipla USA, Inc. 2024-05-01 Health serious FDA
Health · FDA · Recall #FDA-D-0471-2024
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL… Recall
Issued May 1, 2024 · Cipla USA, Inc.
In May 2024, Cipla USA, Inc. recalled the Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
What you should do
- 1 Stop using Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Cipla USA, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Cipla USA, Inc.
- Category
- Health
- Recall date
- May 1, 2024
- Units affected
- Not reported
- Sold at
- USA nationwide.
- Recall number
- FDA-D-0471-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Cipla USA, Inc. has 9 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.